Graham Steel has been involved in Patient Advocacy since 2001 and is a strong advocate and vocal supporter of Open Access, Open Data and Free Culture (interview). In the guest post below, Graham describes the importance of access to clinical trials, academic articles and data, as well as the personal events that led him to…
Today we are launching a project that will greatly improve how life scientists and clinicians connect with F1000 services globally – and locally – and will give scientists interested in scholarly communication some exciting new opportunities and recognition. This initiative, called F1000 Specialists, will allow enthusiastic users of F1000 services to become official, local representatives…
When we announced our campaign to waive the article processing fee for negative results articles until the end of August, we published a press release with a quote from Ben Goldacre, who has been fighting publication bias in medical research and clinical trials. He has talked about the issue in his book Bad Pharma and…
We at F1000Research have a strong belief in transparency: transparency in peer review; transparency in research that is published, through the release and publication of all the underlying data; and transparency in publication, through acceptance of both positive and the ’unexciting’ negative and null findings to reduce the current positive publication bias. Most scientists we…
(This is part 4 of a series of posts featuring speakers from “Challenging the Science Publishing Status Quo”, an evening of talks about peer review, data sharing, and open access. Previously: Lawrence Kane on rapid publication, Keith Flaherty on publishing negative results , Steven Hyman on sharing datasets, Sue Griffin on transparent peer review) Gary…
(This is part 4 of a series of posts featuring speakers from “Challenging the Science Publishing Status Quo”, an evening of talks about peer review, data sharing, and open access. Previously: Lawrence Kane on rapid publication, Keith Flaherty on publishing negative results , Steven Hyman on sharing datasets ) Sue Griffin is is Dillard Professor…
(This is part 3 of a series of posts featuring speakers from “Challenging the Science Publishing Status Quo”, an evening of talks about peer review, data sharing, and open access. Previously: Lawrence Kane on rapid publication, Keith Flaherty on publishing negative results.) Steven Hyman is Distinguished Service Professor of Stem Cell and Regenerative Biology and…
Advice to the European Medicines Agency (EMA) on data release from clinical trials, published last week, should ultimately help to improve healthcare but reveals widely divided opinion on exactly how data sharing should happen. The advice documents cover different aspects of clinical data sharing and reuse. Five advisory groups discussed: protecting patient confidentiality, data formats,…
(This is part 2 of a series of posts featuring speakers from “Challenging the Science Publishing Status Quo”, an evening of talks about peer review, data sharing, and open access. Previously: Lawrence Kane on rapid publication.) Keith Flaherty is Director of Developmental Therapeutics at the Massachusetts Cancer Center. In his talk he addressed the benefits…
We recently hosted “Challenging the Science Publishing Status Quo”, an evening of talks and discussion with several distinguished speakers. Each guest speaker focused on one particular aspect of publishing and peer review. We’ve recorded all the talks, and will be posting them one by one, starting today, and continuing throughout next week. The guest speaker…
